Beta cell replacement, usually by islet transplant, works but is used in only 5-10% of people with type 1 diabetes, explained Andrew R. Pepper, PhD. Limited supplies of beta cells, survival of grafts post transplantation, the lifelong need for immune suppression, and the risks inherent in cell transplantation are all barriers to this therapy.
Get email updates from ADAMeetingNews.org
Subscribe to get regular news updates about the Scientific Sessions.
You can also subscribe to receive other email communications from the American Diabetes Association.